Informed consent is an ethical and legal requirement for research involving human participants. It is the process where a participant is informed about all aspects of the trial, which are important for the participant to make a decision and after studying all aspects of the trial the participant voluntarily confirms his or her willingness to participate in a particular clinical trial and significance of the research for advancement of medical knowledge and social welfare. The concept of informed consent is embedded in the principles of Nuremberg Code, The Declaration of Helsinki and The Belmont Report. Informed consent is an inevitable requirement prior to every research involving human being as subjects for study. Obtaining consent involves informing the subject about his or her rights, the purpose of the study, procedures to be undertaken, potential risks and benefits of participation, expected duration of study, extent of confidentiality of personal identification and demographic data, so that the participation of subjects in the study is entirely voluntary. This article provides an overview of issues in informed consent: The obligations of investigator, sponsor and Institutional Review Board to protect rights and welfare of human research subjects. It discusses about the basic elements of informed consent and the process to be followed while obtaining informed consent. Some of the circumstances under which informed consent can be waived and ethical challenges faced by physicians in obtaining informed consent from subjects are also highlighted in this article.
24 February 2021 in Journal of the Knowledge Economy
In recent years, there is a great emphasis on transferring inventions and technologies originating from academia to industry through technology transfer/licensing or commercialization. The efforts of the Government of India (GOI) aim to create socially useful innovation through university-industry technology transfer. The objective of the study is to examine and understand enabling factors and barriers for technology transfer among Indian universities. The study covers three key aspects: (1) the awareness and practice of patents and research commercialization among Indian academia, (2) comprehending strategies adapted to commercialize research activities, and (3) barriers in university-industry technology transfer (TT). This paper is an attempt to answer the research question whether current dynamics within Indian universities create an environment for enabling knowledge transfer/commercialization and propose plausible suggestions to enable academia-industry technology transfer. A self- assessed structured methodology is contemplated and applied. Convenience sampling methods were adopted. Administrators of 25 universities overseeing research and development activities/patent cell/incubation cell or industrial collaboration of universities were approached to participate in the study. Indian universities are categorized as (i) public funded universities and (ii) private institutes for the purpose of the study. It is interesting to understand that public funded universities have an advantage in terms of receiving funds and licensing the research to potential industrial partners. The authors further conclude that research undertaken in academia is far from the demands of the industry. Even though the relevant supporting system for enhancing university-industry collaboration is in place, such as establishing technology transfer office (TTO) in the university, they hardly channelize the resources for socially useful innovation. It is important for Indian academia to undertake commercially viable research for the benefit of society.
24 February 2022 in Journal of the Knowledge Economy
Until the end of the eighteenth century, Higher Education Institutions (HEIs) were restricted to generate knowledge for free access to industries which they use for making commercial products. Though HEIs have the potential to contribute to the national economy from their creative and commercially viable R&D output through commercialization of research and Intellectual Property Rights, it was not given the needed importance due to lack of supportive policies. In many developed countries, innovation strategies, Science, Technology, and Innovation (STI) and national Intellectual Property Rights (IPR) policies provided opportunities to HEIs to own and commercialize knowledge they generate. National IPR policy and formulation and implementation of HEI IP policies became crucial for effective implementation, promotion of innovation, generation, and protection of IP in the HEIs. Efficiency of HEI in commercializing research is dependent on national IP policy framework aligning vision and goals of HEI IP policy with national IP policy, objectives, ownership, and revenue sharing mechanism. These are the key indicators for comparing the institutions’ innovation and IP capacity. This paper uses these indicators to discuss the impact of different countries’ (developed, developing, and least developed) national IPR policy frameworks on top-performing HEIs of those countries and to address the research question, how national and HEI IP policies have worked in achieving envisaged economic growth by improving innovation output of the HEIs. It further compares Indian HEI IP policies with global HEIs. We found that there is a greater need for local governments and HEIs to make their incentive strategies and policies in line with their corresponding national frameworks for facilitating the collaboration and commercialization of innovations. Implementing a robust IP policy framework at state/region and HEI level plays a pivotal role in creating an innovation ecosystem supportive to envisaged national economic growth.
3 February 2022 in Journal of the Knowledge Economy
Patenting and technology commercialization activities are rapidly gaining momentum in Indian academia. Currently, there is paucity of data suggesting technology commercialization activities among Indian academia. This study aims to examine issues regarding technology commercialization among Indian academics. The objectives of this study are to (1) understand the policy implications of university-industry technology transfer and (2) propose a conceptual model for technology transfer suitable for Indian scenario. The data included for our analysis is drawn from our previous study of 25 Indian Universities. The orientation of the paper is as follows: “Literature Review” is subdivided into two sub-sections — “Policies Implemented for Leveraging Successful Academic Research Commercialization in the USA, Japan, and Israel” and “University Research Commercialization — Case Studies of Universities in the USA, Japan, and Israel” are presented. “Methodology” deals with the methodology used for the study. “Discussion” is further subdivided into three sections — “Analysis and Comparisons of Policy Implications on University-Industry Technology Transfer,” “Practice of Academic Technology Transfer in Indian Universities/Institutes,” and “Conceptual Model Recommended for University-Industry Tech Commercialization in India.” “Conclusion” concludes the topic. The current practices of academia-industry knowledge commercialization in India are limited, and the paper is an attempt to propose a suitable model to encourage commercialization activities by Indian universities.
1 November 2010 in Medical Devices: Evidence and Research
Abstract: The term medical device includes a wide category of products ranging from therapeutic medical devices exerting their effects locally such as tissue cutting, wound covering or propping open clogged arteries, to highly sophisticated computerized medical equipment and diagnostic medical devices. To achieve uniformity among the national medical device regulatory systems and increase the access to safe, effective, and clinically beneficial medical technologies, the Global Harmonization Task Force (GHTF) was conceived in 1992 by five members: European Union, United States, Australia, Japan, and Canada. All regulated countries have clearly defined medical devices, as has the GHTF. Although GHTF has tried to achieve harmonization with respect to medical devices, some differences still exist in the national laws of the countries of GHTF. Further, regulated countries have classified medical devices on the basis of their associated risk. In the Indian regulatory system, medical devices are still considered as drugs. In 2006, the Medical Device Regulation Bill was recommended to consolidate laws for medical devices and to establish the Medical Device Regulatory Authority of India. In addition, medical devices are not classified by any Indian regulatory authority. Although India has moved towards harmonizing its medical device regulations with those of regulated countries, this study aims to identify whether India should have a vigilance system in harmony with those of GHTF or develop its own system for medical devices.
8 October 2020 in Journal of Pharmaceutical Policy and Practice
Background: A dispensing error can be defined as an inconsistency between the drug prescribed and drug dispensed to a patient. These errors can lead to ineffective and sometimes unwanted pharmaceutical outcomes. Dispensing errors can be harmful or even fatal to patients. Case presentation: The objective to this study was (a) to determine the types and frequency of dispensing errors at the Eric Williams Medical Sciences Complex (EWMSC), (b) to explore the reasons for the occurrence of dispensing errors, and (c) to make suitable recommendations for their prevention. An observational study for a period of 2 weeks was carried out at various in- and outpatient departments of the EWMSC. The observations were carried out during 7:00 am to 3:00 pm. Dispensing errors identified during this period were recorded and analyzed. Results: Sixty-eight errors were identified in the adult outpatient pharmacy of the EWMSC; 19 errors in the pediatric outpatient pharmacy, whereas 22 errors were found in inpatient pharmacy. The most common plausible causes for the dispensing errors include high workload, failure to verify patient information, incorrect data in the pharmacy’s record system, inadequate notes made by pharmacists during prior patient visit, and in a few cases, uncomfortable working conditions. Conclusion: Dispensing errors were encountered in 2.1% of all the prescriptions filled at the EWMSC pharmacies. The factors which influenced these dispensing errors include but are not limited to a heavy workload, distractions, failure to verify patient information, and uncomfortable working conditions.